Gut Microbial Fatty Acid Metabolites Reduce Triacylglycerol Levels in Hepatocytes. by Nanthirudjanar, Tharnath et al.
Title Gut Microbial Fatty Acid Metabolites Reduce TriacylglycerolLevels in Hepatocytes.
Author(s)
Nanthirudjanar, Tharnath; Furumoto, Hidehiro; Zheng, Jiawen;
Kim, Young-Il; Goto, Tsuyoshi; Takahashi, Nobuyuki;
Kawada, Teruo; Park, Si-Bum; Hirata, Akiko; Kitamura,
Nahoko; Kishino, Shigenobu; Ogawa, Jun; Hirata, Takashi;
Sugawara, Tatsuya




The final publication is available at Springer via
http://dx.doi.org/10.1007/s11745-015-4067-z.; The full-text file
will be made open to the public on 23 September 2016 in
accordance with publisher's 'Terms and Conditions for Self-
Archiving'.; This is not the published version. Please cite only











































Laboratory of Marine Bioproducts Technology, Division of Applied Biosciences, Graduate 
School of Agriculture, Kyoto University, Kyoto 606-8502, Japan 
2
Laboratory of Molecular Function of Food, Division of Food Science and Biotechnology, 
Graduate School of Agriculture, Kyoto University, Uji 611-0011, Japan 
3
Laboratory of Fermentation Physiology and Applied Microbiology, Division of Applied Life 
Sciences, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan 
4
Laboratory of Industrial Microbiology, Graduate School of Agriculture, Kyoto University, 
Kyoto 606-8502, Japan 
5
Shijonawate Gakuen University, Daito 574-0011, Japan 
 
* Corresponding author: 
Tatsuya Sugawara 
Laboratory of Marine Bioproducts Technology, Division of Applied Biosciences, Graduate 
School of Agriculture, Kyoto University, Kyoto 606-8502, Japan  










Hydroxy and oxo fatty acids were recently found to be produced as intermediates during gut 
microbial fatty acid metabolism. Lactobacillus plantarum produces these fatty acids from 
unsaturated fatty acids such as linoleic acid. In this study, we investigated the effects of these 
gut microbial fatty acid metabolites on the lipogenesis in liver cells. We screened their effect 
on sterol regulatory element-binding protein-1c (SREBP-1c) expression in synthetic liver X 
receptor α (LXRα) agonist (T0901317)-treated HepG2 cells. The results showed that 10-
hydroxy-12(Z)-octadecenoic acid (18:1) (HYA), 10-hydroxy-6(Z),12(Z)-octadecadienoic acid 
(18:2) (γHYA), 10-oxo-12(Z)-18:1 (KetoA), and 10-oxo-6(Z),12(Z)-18:2 (γKetoA) 
significantly decreased SREBP-1c mRNA expression induced by T0901317. These fatty 
acids also downregulated the mRNA expression of lipogenic genes by suppressing LXRα 
activity and inhibiting SREBP-1 maturation. Oral administration of KetoA, which effectively 
reduced triacylglycerol accumulation and Acetyl-CoA carboxylase 2 (ACC2) expression in 
HepG2 cells, for 2 weeks significantly decreased Srebp-1c, Scd-1, and Acc2 expression in the 
liver of high sucrose diet-fed mice. Our findings suggest that hypolipidemic effect of the fatty 
acid metabolites produced by L. plantarum can be taken advantage of in the treatment of 
cardiovascular diseases or dyslipidemia. 
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CLA  Conjugated linoleic acids 
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DMEM Dulbecco’s modified essential medium 
EPA  Eicosapentaenoic acid 
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α-LNA α-Linolenic acid 
LXRα  Liver X receptor α 
OA  Oleic acid 
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     Lactobacillus plantarum is a non-pathogenic gram-positive bacterium that naturally exists 
in the saliva and gastrointestinal tracts of humans and other mammals. It belongs to the lactic 
acid bacteria family and is commonly used in the fermentation of foods such as vegetables, 
fish, and dairy products [1–3]. Owing to its use as a probiotic, its biotherapeutic applications, 
which include reduction of the incidence of diarrhea, pain, and constipation associated with 
irritable bowel syndrome, bloating, and flatulence, have been increasingly acknowledged [4, 
5]. We previously demonstrated that L. plantarum produces many specific types of 
conjugated linoleic acids (CLAs), which may be responsible for its advantageous effects [6–
9]. Furthermore, it was found that CLA synthesis is part of the process of polyunsaturated 
fatty acids (PUFA) saturation in this strain and that a number of hydroxy and oxo fatty acids 
with diverse chemical structures are produced during the process of PUFA saturation. 
Moreover, the levels of hydroxy fatty acids were found to be much higher in specific 
pathogen-free mice than in germ-free mice, indicating that these fatty acids were generated 
through the metabolism of gastrointestinal microorganisms [10]. These findings suggest that 
lipid metabolism by gastrointestinal microbes affects the health of the host by modifying fatty 
acid profiles.  
     Triacylglycerol (TAG), in either the serum or the liver, is a major risk factor for 
cardiovascular disease (CVD). With respect to the importance of hepatic TAG level, 
nonalcoholic fatty liver disease is highly associated with CVD [11]. Omega-3 (ω-3) PUFAs, 
especially eicosapentaenoic acid (EPA), have been commercially developed as dietary 
supplements due to their various health benefits, particularly their TAG-reducing effects. We 
have previously established that structurally modified EPA such as trans isomers and 
oxidized products resulted in significantly lower lipogenic gene expression than EPA; this 




downregulation resulted in a higher suppression of hepatocellular TAG levels [12, 13]. 
Therefore, the effect of the hydroxy and oxo fatty acids generated by gut microorganisms on 
the lipid metabolism in the host liver is of particular interest. In this study, we investigated 
the effects of fatty acid metabolites produced by L. plantarum on TAG synthesis and 
compared them to the effects of EPA. We also attempted to elucidate the structure-related 
functions of hydroxy and oxo fatty acids in the LXRα and SREBP-1c pathway, which plays 
important roles in lipid metabolism in liver cells.  
 




Various types of hydroxy and oxo fatty acids produced from dietary fatty acids such as 
linoleic acid (LA) by L. plantarum were prepared using previously described methods [6–10] 
(Fig. 1). RA (12-hydroxy-9Z-18:1) and 12-hydroxy-octadecanoic acid (18:0) were obtained 
from Nu-Chek Prep Inc. (Elysian, MN, USA) and Tokyo Chemical Industry Co., Ltd. 
(Tokyo, Japan), respectively. 12-Oxo-9(Z)-18:1 (ketoRA) and 12-oxo-18:0 were prepared 
from RA and 12-hydroxy-18:0, respectively, using Jones oxidation, which is the oxidation of 
a hydroxy group with CrO3 [14] and by further purification using a silica column. The 
purities of the fatty acids were evaluated by gas-liquid chromatography and each fatty acid 
was quantified based on their weights. EPA, LA, oleic acid (OA), and DL-α-tocopherol 
(vitamin E) were purchased from Nacalai Tesque, Inc. (Kyoto, Japan). T0901317 was 
obtained from Cayman Chemicals (Ann Arbor, MI). 
      
 






HepG2 cells (JCRB 1054; Health Science Research Resources Bank, Osaka, Japan) were 
cultured in Dulbecco’s modified essential medium (DMEM; Invitrogen, Carlsbad, CA, USA) 
containing 10% FBS (Invitrogen) and antibiotics (100 unit/mL penicillin and 100 µg/mL 
streptomycin; Life Technologies Corporation, Grand Island, NY, USA) at 37°C in a 
humidified atmosphere in the presence of 5% CO2. 
 
Cell Viability Analysis 
 
Cell viability was assessed using the WST-1 method. HepG2 cells were plated in 96-well 
culture plates at a density of 1.0 × 10
4
 cells/well in 100 µL DMEM containing 10% FBS and 
antibiotics as detailed above, and were incubated at 37°C for 24 h. Each fatty acid was then 
added to the HepG2 cell culture medium with T0901317 (10 nM) in serum-free medium 
containing 0.1% BSA (Sigma-Aldrich, Co., St. Louis, MO, USA). The final ethanol 
concentration was 0.4%. After incubation for 24 h at 37°C, 10 µL of the WST-1 solution 
(Dojindo Laboratories, Co., Kumamoto, Japan) was added to each well to evaluate cell 
viability. After incubation for 100 min at 37°C, the cell viability as measured using a 
microplate reader (Molecular Devices Co., Sunnyvale, CA) at a wavelength of 450 nm. 
 
Determination of mRNA Expression by Real-time RT-PCR in HepG2 Cells 
 
HepG2 cells were seeded on 12-well plates at 2 × 10
5
 cells/mL in DMEM supplemented with 
10% FBS and antibiotics. After 24 h of incubation, each fatty acid was added to the HepG2 
cell culture medium in the presence of T0901317 (10 nM) in serum-free medium containing 




0.1% BSA. The final ethanol concentration was 0.2–0.4%. After 24 h of incubation, total 
RNA was extracted from the cells using Sepasol reagent (Nacalai Tesque Inc.) according to 
the manufacturer’s instructions. Total RNA was treated with RNase-free DNase (Promega, 
Madison, WI, USA) to remove any contaminating genomic DNA. After inactivating the 
DNase by adding DNase stop solution (Promega) and heating at 65°C for 10 min, the RNA 
was transcribed to cDNA using SuperScript RNase II reverse transcriptase (Invitrogen) with 
random hexamers. To quantify mRNA expression, real-time quantitative RT-PCR was 
performed in a thermal cycler (Bio-Rad Laboratories, Hercules, CA, USA) using iQ SYBR 
Green supermix (Bio-Rad Laboratories). Primers used for the quantification of each gene are 
listed in Table 1. All data were normalized to 18S mRNA levels as an endogenous internal 
standard. 
 
Luciferase Reporter Assay 
 
HepG2 cells were grown in DMEM supplemented with 10% FBS and antibiotics at 37°C. A 
luciferase ligand assay was performed using the dual luciferase system (Promega) as 
previously described [15]. For the LXRα activity assay, p3xIR1-tk-Luc, pCMX-hLXRα, and 
pRL-CMV were transfected into HepG2 cells. Transfections into HepG2 cells cultured on 10-
cm dishes were performed using Lipofectamine (Invitrogen) according to the manufacturer’s 
protocol. After transfection for 4 h, the transfected cells were seeded into 96-well plates in 
media containing EPA, LA, 10-hydroxy-12(Z)-octadecenoic acid (18:1) (HYA), 10-hydroxy-
6(Z),12(Z)-octadecadienoic acid (18:2) (γHYA), 10-oxo-12(Z)-18:1 (KetoA), 10-oxo-
6(Z),12(Z)-18:2 (γKetoA), and/or T0901317 (500 nM). The luciferase activity was measured 
after 24 h of incubation. 
 




Lipid extraction and TAG Quantification 
 
HepG2 cells were plated in 6-well plates at 5 × 10
5
 cells/mL for 24 h in DMEM 
supplemented with 10% FBS and antibiotics (as mentioned earlier). The cells were then 
treated with each fatty acid and/or T0901317 (10 nM) in the presence of vitamin E (10 µM) 
in the serum-supplemented medium. Fatty acids, vitamin E, and T0901317 were dissolved in 
ethanol. After incubation for 48 h, lipids were extracted from the cells using chloroform-
methanol (2:1, v/v). Reference control cells were extracted before incubation (zero time 
control). The collected supernatants were gently evaporated under an N2 stream, and TAG 
was quantified using a triglyceride E-test kit (Wako Pure Chemical Industries, Osaka, Japan). 
TAG accumulation during 48 h of incubation with each fatty acid was calculated using a 
minus zero time control. 
 
Cell Fractionation and Immunoblotting 
HepG2 cells were plated on 6-well plates at 5.0 × 10
5
 cells/mL for 24 h in DMEM 
supplemented with 10% FBS and antibiotics. The cells were then treated with HYA, γHYA, 
KetoA, γKetoA, and/or T0901317 (10 nM) in serum-free medium containing 0.1% BSA. 
After incubation for 24 h, the membrane fractions and nuclear extracts from the cells were 
prepared by the method reported in the study by Hannah et al. (16). In brief, the cells were 
harvested by scraping, and the cell suspension was centrifuged at 1,000 × g for 5 min at 4°C. 
The cell pellet was then resuspended in Buffer A (250 mM sucrose, 10 mM Hepes-KOH at 
pH 7.6, 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA) 
containing a protease inhibitor tablet (Complete Mini Protease Inhibitor tablet, Roche, 
Mannheim, Germany). The cell suspension was passed 20 times through a 23-gauge needle 
and centrifuged at 1,000 × g for 5 min at 4°C. The pellet thus obtained was resuspended in 40 




µL of Buffer B (20 mM Hepes-KOH at pH 7.6, 0.42 M NaCl, 2.5% (v/v) glycerol, 1.5 mM 
MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA, and protease inhibitor tablet). This 
suspension was rotated at 4°C for 1 h and centrifuged at 10
5
 × g for 15 min at 4°C. The 
resulting supernatant was designated as the nuclear extract fraction. The supernatant obtained 
after the first 1,000 × g spin was re-centrifuged at 10
4
 × g for 15 min at 4°C, and then the 
pellet was dissolved in 25 µL of SDS lysis buffer (10 mM Tris-HCl at pH 6.8, 100 mM NaCl, 
1% (w/v) SDS, 1 mM sodium EDTA, 1 mM sodium EGTA, and a protease inhibitor tablet) 
and designated as the membrane fraction. The concentration of soluble proteins in the 
supernatant was quantified using a DC protein assay kit (Bio-Rad Laboratories). For the 
immunoblot analysis, given amounts of membrane fractions (25 µg) and nuclear extracts (20 
µg) were separated by 7% and 10% SDS-PAGE, respectively. Protein bands were transferred 
to polyvinylidene difluoride membranes (Millipore Corporation, MA). The filters were 
probed with rabbit polyclonal anti-SREBP-1 antibody (H-160, 1:400 dilution; Santa Cruz 
Biotechnology, Santa Cruz, CA). Bound antibodies were visualized using alkaline 
phosphatase-conjugated anti-rabbit IgG (1:500 dilution; Cell Signaling Technology, Danvers, 
MA), and the bands were visualized using the substrate, chemi-lumione L (Nacalai Tesque), 




All experimental animal protocols were approved by the Animal Experimentation Committee 
of Kyoto University for the care and use of experimental animals. Six-week-old male ICR 
mice (Japan SLC, Inc) were kept in individual cages in a temperature-controlled facility with 
a constant 12-h light/dark cycle. The mice were divided into 2 groups and maintained on 40% 
high-sucrose diet (Table 2). KetoA (5 mg/mouse/day) in PBS containing 5% DMSO and 




0.5% polysorbate 20 was administrated to each mouse in the experimental group by oral 
gavage for 2 weeks. After fasting for 16 h, the mice were euthanized under isoflurane 
anesthesia. The liver was excised, and total RNA and total lipids were extracted. To quantify 
mRNA expression, real-time quantitative RT-PCR was performed. Primers used for the 
quantification of each gene are listed in Table 3. The values were normalized against those 
for Gapdh that was used as an endogenous internal standard. TAG was quantified using a 




Data are reported as means ± standard deviation (SD). Statistical analyses were conducted 
using Student’s t-test or one-way ANOVA with Scheffe’s F-test to identify significant 




L. plantarum converted unsaturated fatty acids such as LA through saturation into diverse 
hydroxy and oxo fatty acids that have a hydroxy or oxo group at the C10 position and double 
bonds at different locations (Fig. 1). The effects of these C10-hydroxy and -oxo fatty acids 
were investigated in comparison with those of dietary fatty acids such as OA, LA, and EPA 
and structurally related C12-hydroxy and -oxo fatty acids such as RA (which is abundant in 
castor oil), KetoRA, 12-hydroxy-18:0, and 12-oxo-18:0.  
To determine the effects of each compound on cell viability, various concentrations of 
fatty acids and T0901317 were added to HepG2 cells. Fig. 2 shows the result of the cell 
viability assay after 24 h of treatment. None of the fatty acids, excluding 60 µM EPA, HYB 




and 12-hydroxy-18:0, had significant cytotoxic effects). In agreement with the results of this 
experiment, EPA, which is famous for its hypolipidemic effect, is well known for its high 
cytotoxic effect [17]. 
After 24 h of induction with 10 nM T0901317, SREBP-1c mRNA expression in HepG2 
cells was more than 6-fold higher than that in the vehicle-treated cells. Most of the C10-
hydroxy and -oxo fatty acids produced by L. plantarum, except 10-oxo-18:0 (KetoB), 
significantly reduced the T0901317-induced SREBP-1c mRNA expression; this effect was 
also observed with EPA, but not with LA. SREBP-1c mRNA levels in the HYA, γHYA, 
KetoA, and γKetoA treatment groups were significantly different from those of the LA 
treatment group. These four derivatives contained hydroxy or oxo groups at the same position 
(C10) and the double bond was located at ∆12. 10-Hydroxy-12(Z),15(Z)-18:2 (αHYA) and 
10-oxo-12(Z),15(Z)-18:2 (αKetoA), which were derived from an omega-3 (ω3) PUFA, α-
LnA, also demonstrated the same activity, albeit at a slightly lower level than HYA, KetoA, 
γHYA, and γKetoA, which were derived from an omega-6 (ω6) PUFA, LA or γ-LnA. 
Structurally related RA, 12-hydroxy-18:0, and 12-oxo-18:0 with hydroxy or oxo groups at 
C12, but not KetoRA, also showed slightly weaker effects on SREBP-1c mRNA expression 
in HepG2 cells (Fig. 3).  
     After 48 h of incubation, T0901317 significantly increased cellular TAG levels to 
approximately 14 µg/mg of protein in HepG2 cells. TAG accumulation in L. plantarum fatty 
acid metabolite-treated cells was significantly lower than that of the T0901317-activated 
cells. KetoA, which contains an oxo group at C10, most effectively reduced TAG levels. 
HYA, KetoA, and γKetoA showed significantly stronger hypolipidemic effects than EPA 
(Fig. 4).  
     In the presence of T0901317, LXRα reporter activity in HepG2 cells was approximately 4-
fold higher than that in the vehicle-treated cells. In our luciferase reporter assay, EPA, HYA, 




γHYA, KetoA, and γKetoA significantly decreased the LXRα reporter activity induced by 
T0901317 in a dose-dependent manner (Fig. 5A). These results indicated that the suppressive 
effect of these fatty acids on SREBP-1c mRNA expression was regulated through LXRα.  
Next, the effect of these fatty acid metabolites on the mRNA levels of lipogenic gene was 
evaluated. HYA, γHYA, KetoA, and γKetoA significantly decreased stearoyl-CoA 
desaturase-1 (SCD-1) and FAS mRNA expression, as did EPA and LA (Fig. 5B and C). In 
addition, HYA, γHYA, KetoA, and γKetoA significantly decreased the T0901317-induced 
expression of ACC1 and ACC2 in a similar fashion as did EPA, but not as LA did (Fig. 5D 
and E). The decrease in ACC2 mRNA levels caused due to HYA and KetoA was significantly 
more than that observed with EPA. 
     To investigate the effect of these fatty acids on SREBP-1 protein levels, the full-length 
precursor form of the protein in the cell membrane (125 kDa) and the cleaved mature form 
(68 kDa) in the nuclear extract were estimated by immunoblotting. Because the used antibody 
cannot distinguish between the SREBP-1c and -1a isoforms, we use the general term SREBP-
1 to refer to the results. T0901317 increased the levels of both the precursor and the mature 
forms of SREBP-1 (Fig. 6A and B). HYA, γHYA, KetoA and γKetoA, as well as EPA, 
decreased the T0901317-mediated induction of the expression of both the precursor and 
mature forms of SREBP-1. Interestingly, the expression of the mature form of SREBP-1 was 
more significantly downregulated by HYA, γHYA, KetoA, and γKetoA than by EPA. 
     In this study, the dietary effects of fatty acid metabolites produced by L. plantarum were 
examined in vivo. KetoA, which was the most efficient in reducing TAG accumulation and 
ACC2 expression in HepG2 cells, was administrated to high-sucrose diet fed-mice for 2 
weeks. The mRNA expression of Srebp-1c, Scd-1, and Acc2 was significantly lower in the 
KetoA group than in the control group, but the liver TAG content was not different from that 
in the control group (Fig 7).  








In the present study, the biological effects of hydroxy and oxo fatty acids, which can be 
produced by gut microorganisms from dietary fatty acids, were evaluated. We decided to 
study the effects of these hydroxy and oxo fatty acids on the LXRα and SREBP-1c lipogenic 
pathway in the liver, because this pathway may be a potential target for the treatment of 
atherosclerosis and other metabolic diseases. We used T0901317 to develop an immoderate 
lipid synthesis model by upregulating LXRα and SREBP-1c expression. In this study, we 
focused on the hypolipidemic effect of the hydroxy and oxo fatty acids on hepatic cells. The 
hypolipidemic effect of PUFAs is attributable both to a decrease in lipogenesis and to an 
increase in fatty acid catabolism through the regulation of SREBP-1 and PPARα, respectively 
[18]. Nevertheless, it is well known that PPARα is weakly expressed and has very low 
function in HepG2 cells, because these cells originate from hepatomas and some kinds of 
genes, such as PPARα, are mutated [19]. Thus, we focused on the regulation of lipogenesis 
via SREBP-1c. 
     In our results, most of C10-hydroxy and -oxo fatty acids produced by L. plantarum, except 
KetoB and the plant fatty acid-derived KetoRA, significantly reduced T0901317-induced 
SREBP-1c mRNA expression. In addition, HYA, γHYA, KetoA, and γKetoA caused a more 
significant decrease in SREBP-1c mRNA expression than did LA; this effect, however, was 
not observed with RA. Thus, the effects of C10-hydroxy and -oxo fatty acids seem to be 
relatively more potent than those of C12-hydroxy and -oxo fatty acids. The luciferase assay 
revealed that, similar to EPA, some oxo- and hydroxy-octadecenoic and octadecadienoic 
acids produced from unsaturated fatty acids by L. plantarum, including HYA, γHYA, KetoA, 




and γKetoA, dose-dependently decrease LXRα activation [12]. This result indicated that 
HYA, γHYA, KetoA, and γKetoA reduced SREBP-1c mRNA expression by competing with 
T0901317 for LXRα activation, similar to EPA. This important mechanism may explain how 
these fatty acids can potently reduce cellular TAG synthesis that was induced by an LXRα 
agonist. In parallel with a previous study (20), we found that EPA decreased SREBP-1 
maturation by reducing the T0901317-induced expression of both the precursor and mature 
forms of the SREBP-1 protein. HYA, γHYA, KetoA and γKetoA repressed the expression of 
precursor SREBP-1 to the same level as did EPA, but the decrease in the expression of 
mature SREBP-1 caused by these metabolites was significantly higher than that observed 
with EPA. Elucidation of the regulation of factors related to the maturation of SREBP-1, such 
as insulin-induced gene (INSIG), SREBP cleavage-activating protein (SCAP), and site-1 
protease (S1P), might help explain the reason for this difference in the effects of these 
metabolites with regard to suppression of mature SREBP-1 expression. 
     HYA, γHYA, KetoA, and γKetoA also reduced the mRNA expression of the target genes 
of SREBP-1c, such as FAS, SCD-1, and ACC1, which were involved in de novo fatty acid 
synthesis. The increase in ACC2 mRNA expression and TAG accumulation in T0901317-
induced cells was reduced by HYA and KetoA to a level that was significantly lower than 
that observed in EPA-treated cells. This finding indicated that ACC2 is a crucial factor 
influencing the effects of hydroxy and oxo fatty acids on lipid metabolism. ACC2 plays a 
major role in energy homeostasis by converting acetyl-CoA to malonyl-CoA. Malonyl-CoA 
inhibition of CPT1 is a mechanism that controls the two opposing pathways: fatty acid 
synthesis and β-oxidation [21, 22]. ACC2 is located on the mitochondrial membrane and is 
highly expressed in tissues with a high rate of fatty acid oxidation, such as the adipose tissue, 
skeletal muscles, and the liver [22, 23]. This hypothesis was further supported by the results 
of a study on Acc2
−/− 
mutant mice. These mice continuously oxidized fatty acids, ate more 




food, and gained less weight than the wild-type mice [24]. Therefore, ACC2-suppressive 
effect may be preferable to increase fatty acid β-oxidation and decrease lipid accumulation.  
     The lipogenesis-suppressive effect of fatty acid metabolites produced by L. plantarum 
might be due to a significant reduction in SREBP-1c and ACC2 levels via a decrease in their 
mRNA expression. These findings suggest that HYA, γHYA, KetoA, and γKetoA might be 
novel alternatives that can be utilized in the treatment of CVD, atherosclerosis, or any other 
diseases that are caused by SREBP-1c overexpression, particularly through a hepatic insulin 
signaling-dependent pathway, which is required for SREBP-1c processing, maximal 
lipogenic gene expression, and steatosis induction [25]. In our animal experiment, oral 
administration of KetoA, the most efficient fatty acid to reduce TAG accumulation and ACC2 
expression in HepG2 cells, significantly decreased the hepatic gene expression of Srebp-1c, 
Scd-1 and Acc2, but did not affect the TAG content in the liver. Further studies are required 
to investigate the potential effects of these hydroxy and oxo fatty acids on lipid metabolism 
and their bioavailability and metabolic fate in vivo.  
     In addition, it will be interesting to investigate th  probiotic effects of L. plantarum on the 
health of a host fed a PUFA-rich diet. The results of the present study also show that gut 
microbial metabolites from PUFA are more effective against hepatic cellular TAG 
accumulation than those from monounsaturated fatty acids such as OA. The metabolites 
derived from ω6 PUFA showed higher activity than those derived from ω3 PUFA. These 
observations indicate that the ω6 and ω3 PUFA content of the food together with the PUFA-
saturation activity of gut microbiota have an effect on specific health conditions.  
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Fig. 1 Chemical structure of hydroxy and oxo fatty acids produced by Lactobacillus 
plantarum and structurally related hydroxy and oxo fatty acids. 
 
Fig. 2 Effects of EPA, LA, OA, or hydroxy and oxo fatty acids on cell viability as determined 
by the water-soluble tetrazolium (WST)-1 assay. Data are reported as means ± SD (n = 
4/group). A significant difference as compared to the vehicle control group was shown as 
follows: * p < 0.05. 
 
Fig. 3 Effects of EPA, LA, OA, or hydroxy and oxo fatty acids on SREBP-1c mRNA 
expression in HepG2 cells. Data are reported as means ± SD (n = 3). *Significantly different 
from the T0901317-induced control (p < 0.05). 
 
Fig. 4 Effects of EPA, LA, 10-hydroxy-12Z-octadecenoic acid (18:1) (HYA), 10-hydroxy-
6Z,12Z-octadecadienoic acid (18:2) (γHYA), 10-oxo-12Z-18:1 (KetoA), and 10-oxo-6Z,12Z-
18:2 (γKetoA) on triacylglycerol synthesis in HepG2 cells. The increased TAG levels (TAG 
levels after 48 h of incubation minus the levels in reference cells before incubation) are 




shown. Data are reported as means ± SD (n = 4). Means indicated with different letters 
showed statistically significant differences, as determined by Scheffe’s F-test (p < 0.05). 
 
 
Fig. 5 Suppression of pLXREs-Luc expression by EPA, LA, HYA, γHYA, KetoA, and 
γKetoA (a). Data are reported as means ± standard deviation (SD, n = 5). *Significantly 
different from the T0901317-induced control (p < 0.05). Effects of these fatty acids on the 
mRNA expression of stearoyl-CoA desaturase-1 (SCD-1, b), fatty acid synthase (FAS, c), 
acetyl-CoA carboxylase-1 (ACC1, d), and acetyl-CoA carboxylase-2 (ACC2, e). Data are 
reported as means ± SD (n = 3). Means indicated with different letters showed statistically 
significant differences, as determined by Scheffe’s F-test (p < 0.05).  
 
Fig. 6 Effects of HYA, γHYA, KetoA, or γKetoA on the expressions of the precursor (A) and 
mature (B) forms of sterol-regulatory element binding protein-1 (SREBP-1) protein. Data are 
reported as means ± SD (n = 3-4/group).  
Means indicated with different letters showed statistically significant differences, as 
determined by Scheffe’s F-test (p < 0.05).  
 
Fig. 7 Effect of dietary KetoA on triacylglycerol and mRNA expression in the liver of high-
sucrose diet-fed mice. Data are reported as means ± SD (n = 5). *Significantly different from 
the control group, as determined by Student’s t-test (p < 0.05). 
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Table 1. Real-time RT-PCR primers used for the quantification of human mRNAs 




(from 5’ to 3’)  
Reverse 
(from 5’ to 3’)  
SREBP-1c  [1] GGAGGGGTAGGGCCAACGGCCT  CATGTCTTCGAAAGTGCAATCC  
SCD-1  NM_005063  TGGTTTCACTTGGAGCTGTG  GGCCTTGGAGACTTTCTTCC  
FAS  [1] ACAGGGACAACCTGGAGTTCT  CTGTGGTCCCACTTGATGAGT  
ACC1  NM_198834  ATCCCGTACCTTCTTCTACTG  CCCAAACATAAGCCTTCACTG  
ACC2  NM_001093 CTCTGACCATGTTCGTTCTC  ATCTTCATCACCTCCATCTC  
18s  [1] TAAGTCCCTGCCCTTTGTACACA  GATCCGAGGGCCTCACTAAAC  
[1] F.J. Field, E. Born, S. Murthy, S.N. Mathur, Poly-unsaturated fatty acids decrease the expression of 
sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol 
transport, Biochem. J. 368 (2002) 357-363. 
 
 
Table 2. Composition of high sucrose diet 
Ingredient  (weight %) 
β-Cornstarch 10 
Casein 20 
Dextrinized cornstarch 13.2 
Sucrose 39.7486 
Soybean oil 7 
Cellulose powder 5 
AIN-93 mineral mix 3.5 
AIN-93 vitamin mix 1 
L-Cystine 0.3 
Choline bitartrate 0.25 
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Table 3. Real-time RT-PCR primers used for the quantification of mouse mRNAs 




(from 5’ to 3’)  
Reverse 
(from 5’ to 3’)  
SREBP-1c  NM_011480 GGAGCCATGGATTGCACATT GCTTCCAGAGAGGAGCCCAG  




ACC2  [2] GACGCCCGAGGATCTGAAG  GGGACAGGGACGTACTGATC  
GADPH  NM_008084.2  CGTCCCGTAGACAAAATGGT TGCCGTGAGTGGAGTCATAC  
[2] J.C. Castle, Y. Hara, C.K. Raymond, P. Garret-Engee, K. Ohwaki, Z. Kan, J. Kusunoki, J.M. Johnson, 
ACC2 is expressed at high levels human white adipose and has an isoform with a novel N-Terminus, PloS 
One 4 (2009) e4369. 
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10-hydroxy-18:0 (HYB) 
10-hydroxy-12Z-18:1 (HYA) 6Z-10-hydroxy-12Z-18:2 (ɣHYA) 
10-hydroxy-12Z,15Z-18:2 (αHYA) 
10-oxo-18:0 (KetoB) 






Hydroxy- and oxo-fatty acids produced by L. plantarum Structurally related C12 hydroxy- and 
oxo-fatty acids 
From oleic acid 
From linoleic acid 
From a-linolenic acid 
From g-linolenic acid 
Fig. 1. 



























































































































































































































Fatty acid  
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60 mM 


























































































































































A. Luc activity 
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(A) Precursor SREBP-1 
(B) Mature SREBP-1 
Control HYA Normal KetoA γHYA γKetoA 
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